BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9307594)

  • 1. Polysaccharide vaccines: determinants of clinical efficacy.
    Musher DM
    Hosp Pract (1995); 1997 Sep; 32(9):37-8, 41-4, 52-3 passim. PubMed ID: 9307594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of immunology to the rational design of novel antibacterial vaccines.
    Kaufmann SH
    Nat Rev Microbiol; 2007 Jul; 5(7):491-504. PubMed ID: 17558425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsular polysaccharide and conjugate vaccines.
    Mäkelä PH
    Zentralbl Bakteriol; 1994 Oct; 281(3):334-9. PubMed ID: 7696754
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-capsular polysaccharide antibody deficiency states.
    Rijkers GT; Sanders LA; Zegers BJ
    Immunodeficiency; 1993; 5(1):1-21. PubMed ID: 8167745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of polysaccharide-specific antibody responses to isolated polysaccharides, conjugate vaccines, and intact Gram-positive versus Gram-negative extracellular bacteria.
    Snapper CM
    Vaccine; 2016 Jun; 34(30):3542-8. PubMed ID: 27133879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsular antigens of bacteria. Capsular antigens as the basis of vaccines against pathogenic bacteria.
    Ovodov YS
    Biochemistry (Mosc); 2006 Sep; 71(9):955-61. PubMed ID: 17009948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Capsular polysaccharide of Klebsiella pneumoniae. II. Immunogenic properties].
    Alcántar-Curiel MD; Martínez-Ramos A; García-Latorre E
    Rev Latinoam Microbiol; 1993; 35(1):109-15. PubMed ID: 8140330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood.
    Goldblatt D; Levinsky RJ; Turner MW
    J Infect Dis; 1992 Sep; 166(3):632-4. PubMed ID: 1500747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In memoriam Dr. István Joó (1912-1993)].
    Ralovich B
    Orv Hetil; 2009 Nov; 150(46):2124-5. PubMed ID: 19889601
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccines: past, present and future.
    Plotkin SA
    Nat Med; 2005 Apr; 11(4 Suppl):S5-11. PubMed ID: 15812490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines.
    Robbins JB; Schneerson R; Anderson P; Smith DH
    JAMA; 1996 Oct; 276(14):1181-5. PubMed ID: 8827975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief history of the prevention of infectious diseases by immunisations.
    Bazin H
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):293-308. PubMed ID: 12818618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The history of live bacterial vaccines.
    Lindberg AA
    Dev Biol Stand; 1995; 84():211-9. PubMed ID: 7796956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The development of live vaccines in the Soviet Union. (Review) Live bacterial vaccines].
    Kravchenko AT; Saltykov RA
    Zh Mikrobiol Epidemiol Immunobiol; 1967; 44(3):3-9. PubMed ID: 4894102
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacteriophage therapy for bacterial infections. Rekindling a memory from the pre-antibiotics era.
    Ho K
    Perspect Biol Med; 2001; 44(1):1-16. PubMed ID: 11253299
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with Salmonella typhi Vi capsular polysaccharide vaccine.
    Hessel L; Debois H; Fletcher M; Dumas R
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):609-20. PubMed ID: 10534182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies and bacterial meningitis.
    Mäkelä PH
    Trans R Soc Trop Med Hyg; 1991; 85 Suppl 1():19-22. PubMed ID: 1803693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative and quantitative immune response to bacterial capsular polysaccharides and their conjugates in mouse and man.
    Fattom A
    Adv Exp Med Biol; 1995; 383():131-9. PubMed ID: 8644498
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular versus humoral immunology: a century-long dispute.
    Silverstein AM
    Nat Immunol; 2003 May; 4(5):425-8. PubMed ID: 12719732
    [No Abstract]   [Full Text] [Related]  

  • 20. Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants.
    Barrett DJ
    Adv Pediatr; 1985; 32():139-58. PubMed ID: 3909772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.